Develops prescription digital therapeutic apps that deliver personalized treatment interventions for medical conditions through behavior modification.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Overview
CureApp develops evidence-based digital therapeutics (DTx) applications designed to treat conditions that have not been effectively addressed by conventional therapies. Their prescription DTx apps focus on behavior modification, providing personalized treatment interventions through mobile applications.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
CureApp Management Team
CureApp Valuations & Financials
View real-time NPM data on CureApp stock including daily CureApp stock price estimates, valuation history, and historical share price information. Access CureApp financing rounds, secondary trade levels, cap table data, and private company comparable transactions. Use NPM's private company valuation database to track CureApp pricing across six independent market signals. Looking for private company due diligence data sources on CureApp? Get in touch to learn more.
Similar Companies
like CureApp
Podium
Enterprise Software
Customer messaging platform enabling companies to connect at critical touch points.
Deep Fission
Climate & Sustainability
Accelerates large‑model performance by optimizing interactions between neural models and hardware.
Sentra
Cybersecurity
Cloud-based platform that discovers sensitive data vulnerabilities, detects misconfigurations, and remedies security risks in public environments.
RxAnte
Healthcare & Life Sciences
Uses predictive analytics and clinical programs to improve medication use, adherence, and healthcare outcomes for health plans.
Frontier Risk Group
FinTech
Offers cannabis‑industry businesses streamlined access to specialized insurance solutions that address unique regulatory and operational risks.
Interdict Bio
Healthcare & Life Sciences
Expert innovator enabling targeted protein synthesis modulation for disease therapies using context-specific small molecules.
Zuma
AI & Machine Learning
Automates leasing, collections, and prospect engagement across the full resident lifecycle.
RecoveryOne
Healthcare & Life Sciences
Digital platform delivering personalized rehabilitation programs with guided exercises and expert support for injury recovery and pain management.
Leaf Logistics
Commerce & Marketplaces
A logistics technology company that facilitates collaboration among shippers, carriers, and brokers to optimize freight scheduling and reduce waste.
FAQ
We have answers
CureApp stock does not trade on public stock exchanges. CureApp stock is considered a private security and you need to be an accredited investor to trade shares. To invest in CureApp stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.
Learn more about the secondary market for private company shares on the investors page.
CureApp Stock does not trade on public stock exchanges. In order to sell CureApp shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.
Learn more about NPM services for selling privately held stock on the Employee Shareholders page.
Read more about how to sell private company stock on the private secondary market:
CureApp does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the NPM Data and Intelligence database from Nasdaq Private Market, you can view CureApp share price and other valuable private market data.
Read more about secondary market private company stock prices:
There is no ticker symbol for CureApp stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.
Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell CureApp stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Learn more about selling privately held stock on the Employee Shareholders page.
Read more about how to sell shares of a private company and eligibility for selling privately held stock:
Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in CureApp stock, you need to be an accredited entity or institutional investor.
Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.
Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.
CureApp is a private company and has not had an IPO. There is currently no CureApp IPO price. Get started to begin exploring the Nasdaq Private Market Data and Intelligence database and gain access to actionable data related to CureApp IPO.
Learn more about Data and Intelligence private company stock data for institutional investors on the on the NPM Data and Intelligence Product Page.
